Literature DB >> 18354162

Innate-like effector differentiation of human invariant NKT cells driven by IL-7.

Claudia de Lalla1, Nicola Festuccia, Inka Albrecht, Hyun-Dong Chang, Grazia Andolfi, Ulrike Benninghoff, Ferdinando Bombelli, Giovanna Borsellino, Alessandro Aiuti, Andreas Radbruch, Paolo Dellabona, Giulia Casorati.   

Abstract

Conventional MHC-restricted T lymphocytes leave thymus with a naive phenotype and require Ag-dependent stimulation coupled to proliferation to acquire effector functions. Invariant (i)NKT cells are a subset of T lymphocytes considered innate because they display an effector memory phenotype independent of TCR stimulation by foreign Ags. We investigated the effector differentiation program followed by human iNKT cells by studying cells from a relevant set of fetal thymi and umbilical cord blood samples. We find that human fetal iNKT cells have already started a differentiation program that activates the epigenetic and transcriptional control of ifng and il4 genes, leading at birth to cells that express these cytokines upon TCR signaling but independently of proliferation in vitro. Both ex vivo and in vitro analysis of fetal and neonatal iNKT cells delineate an effector differentiation program linked to cell division in vivo, and they identify IL-7 as one of the crucial signals driving this program in the apparent absence of Ag stimulation. Consistent with these data, human fetal and neonatal iNKT cells are hyperresponsive in vitro to IL-7 in comparison to conventional T cells, owing to an increased expression and signaling function of the IL-7 receptor alpha-chain. The innate nature of human iNKT cells could thus derive from lineage-specific developmental cues that selectively make these cells efficient IL-7 responders following thymic selection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18354162     DOI: 10.4049/jimmunol.180.7.4415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Natural killer T cells constitutively expressing the interleukin-2 receptor α chain early in life are primed to respond to lower antigenic stimulation.

Authors:  Mihoko Ladd; Ashish Sharma; Qing Huang; Adele Y Wang; Lixin Xu; Indira Genowati; Megan K Levings; Pascal M Lavoie
Journal:  Immunology       Date:  2010-10       Impact factor: 7.397

Review 2.  Ex vivo purification and characterization of human invariant Natural Killer T cells.

Authors:  Ashish Arunkumar Sharma; Leon Chew; Mihoko Ladd; Roger Jen; Pascal M Lavoie
Journal:  J Immunol Methods       Date:  2011-08-11       Impact factor: 2.303

3.  Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.

Authors:  F A Vyth-Dreese; J Sein; W van de Kasteele; T A M Dellemijn; C van den Bogaard; W J Nooijen; G C de Gast; J B A G Haanen; A Bex
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

4.  EBV promotes human CD8 NKT cell development.

Authors:  Yuling He; Ruijing Xiao; Xiang Ji; Li Li; Lang Chen; Jie Xiong; Wei Xiao; Yujuan Wang; Lijun Zhang; Rui Zhou; Xinti Tan; Yongyi Bi; Yan-Ping Jiang; Youxin Jin; Jinquan Tan
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

5.  Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells.

Authors:  Kyle K Payne; Christine K Zoon; Wen Wan; Khin Marlar; Rebecca C Keim; Mehrab Nasiri Kenari; A Latif Kazim; Harry D Bear; Masoud H Manjili
Journal:  Breast Cancer Res Treat       Date:  2013-10-25       Impact factor: 4.872

6.  Murine neonatal recent thymic emigrants are phenotypically and functionally distinct from adult recent thymic emigrants.

Authors:  Shannon J Opiela; Tulay Koru-Sengul; Becky Adkins
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

7.  Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity.

Authors:  Kelly Andrews; Anouk A J Hamers; Xiaodian Sun; Geoffrey Neale; Katherine Verbist; Paige Tedrick; Kim E Nichols; Shalini Pereira; Daniel E Geraghty; Asha B Pillai
Journal:  Cytotherapy       Date:  2020-03-29       Impact factor: 5.414

8.  Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine.

Authors:  L Loh; M A Ivarsson; J Michaëlsson; J K Sandberg; D F Nixon
Journal:  Mucosal Immunol       Date:  2014-03-19       Impact factor: 7.313

9.  Chronic stress physically spares but functionally impairs innate-like invariant T cells.

Authors:  Patrick T Rudak; Joshua Choi; Katie M Parkins; Kelly L Summers; Dwayne N Jackson; Paula J Foster; Anton I Skaro; Ken Leslie; Vivian C McAlister; Vijay K Kuchroo; Wataru Inoue; Olivier Lantz; S M Mansour Haeryfar
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

10.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Authors:  Zhenpeng Dai; Cameron J Turtle; Garrett C Booth; Stanley R Riddell; Theodore A Gooley; Anne M Stevens; Thomas Spies; Veronika Groh
Journal:  J Exp Med       Date:  2009-03-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.